Unknown

Dataset Information

Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer.


ABSTRACT:

Purpose

There are sparse data describing outcomes of bone-only oligometastatic prostate cancer in comparison with lymph node disease treated with stereotactic body radiotherapy (SBRT). The primary aim of this study was to report progression-free survival (PFS) data for patients with bone-only disease. Influence of hormone sensitivity and androgen deprivation therapy use was also assessed.

Methods

This is a single-centre retrospective cohort study. Hormone-sensitive and castrate-resistant patients with oligometastatic (≤ 3) bone-only prostate cancer treated with SBRT were included. Data were collected using electronic records. Kaplan-Meier survivor function, log rank test, as well as Cox regression were used to calculate PFS and overall survival.

Results

In total, 51 p

SUBMITTER: Patel PH 

PROVIDER: S-EPMC6868044 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature